This study, in biologically bred hyperglycemic diabetic rats, examined the effect of an intravenous insulin infusion (1.5 units -hr" 1 ) on blood, plasma, and brain glucose concentrations to determine their relationship during decreasing blood and plasma glucose levels. The data were compared to saline-treated diabetic rats and saline-treated nondiabetic littermates. The volume and duration of the treatment infusion were similar in all groups. Insulin infusion in diabetic rats produced the expected reduction in blood and plasma glucose, and normoglycemia was produced within 78±37 minutes (mean±SD). However, once normoglycemia was achieved, brain glucose was still significantly greater by 44% than in nondiabetic rats (p=0.015). Moreover, the ratio of brain to plasma glucose was more than 50% greater in diabetic than nondiabetic rats, irrespective of whether or not they received insulin (p<0.01). We conclude that measurement of blood or plasma glucose in diabetic subjects will tend to underestimate the amount of glucose in the brain and that this relationship is not influenced by acute insulin therapy. {Stroke 1991^22:505-509) H yperglycemia and increases in brain glucose will exacerbate cerebral injury during and after a period of global ischemia. 1 -8 An increase in brain glucose also may contribute to the worsened neurologic outcome in untreated diabetics after resuscitation from cardiac arrest.2 The effect of insulin treatment (resulting in nonnoglycemia) on brain glucose and its effect on postischemic neurologic injury has not been reported. Previous studies in this laboratory investigated the effects of insulin treatment on plasma and brain glucose concentrations in streptozocin-induced diabetic rats. 9 These studies found that when insulin was used to achieve normoglycemia over a 2-hour period in diabetic rats, normoglycemic diabetic rats had a greater amount of glucose (>25%) in the brain than did normoglycemic, nondiabetic rats. Our data suggested that this finding is due to an alteration in the manner in which the diabetic brain handles glucose and is not due to an insulin effect or a hysteresis effect.Streptozocin has been used as a means of inducing diabetes resembling human juvenile-onset diabetes 10 in various animal models through its propensity to lower the nicotinamide adenine dinucleotide and its consequent histopathologic alteration of the insulin-producing islet beta cells of the pancreas.
11Because of the mechanism of action of streptozocin, From the Department of Anesthesiology, Mayo Clinic, Rochester, Minn.Supported by a grant from the American Heart Association, Minnesota Affiliate.Address for reprints: William L. Lanier, MD, Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905.Received September 11, 1990; accepted December 17, 1990. it is possible that the drug also may affect organs other than the pancreas. Thus, our previously reported data describing alterations in brain glucose metabolism in streptozocin-induced diabetic rats may have been due to one or both of the followi...